Bismuth subsalicylate 262 mg [Kaopectate Reformulated Aug 2006]
RxNorm 642347

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 642347 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: bismuth subsalicylate 262 mg [Kaopectate Reformulated Aug 2006].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDC
Bismuth subsalicylate 262 mg [Kaopectate Reformulated Aug 2006]
AUI:2542203
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDCPrescribable

Semantic Branded Drug Component (SBDC):
Bismuth subsalicylate 262 mg [Kaopectate Reformulated Aug 2006]
(Atom ID: 2542203)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
bismuth subsalicylate 262 MG [Kaopectate Reformulated Aug 2006]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
642347
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
2542203
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDC
Semantic Branded Drug Component (Ingredient + Strength + Brand Name)
Source Code
642347
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN ACTIVATED
02/25/2020
Date the RxNorm atom was reactivated
RXN ACTIVATED
08/27/2014
Date the RxNorm atom was reactivated
RXN OBSOLETED
01/02/2020
Date the RxNorm atom became obsolete
RXN OBSOLETED
02/27/2013
Date the RxNorm atom became obsolete

Patient Education

Bismuth Subsalicylate


Bismuth subsalicylate is used to treat diarrhea, heartburn, and upset stomach in adults and children 12 years of age and older. Bismuth subsalicylate is in a class of medications called antidiarrheal agents. It works by decreasing the flow of fluids and electrolytes into the bowel, reduces inflammation within the intestine, and may kill the organisms that can cause diarrhea.
[Learn More]


* Please review the disclaimer below.